Identity
- Trade Name
- Genemed® FDA UDI
- Generic Name
- Non-specific circulating immune complex (CIC) IVD, kit, enzyme immunoassay (EIA) FDA UDI
- Device Name
- Blocking Solution (Non-immune), Ready-To-Use, 100 mL FDA UDI
- Model / Reference
- 10-0032 FDA UDI
- Description
- Blocking Solution (Non-immune), Ready-To-Use, 100 mL FDA UDI
Identifiers
- Catalog Number
- 10-0032 FDA UDI
- Primary DI / UDI-DI
- 00615233006998 FDA UDI
- FDA Product Code
- PPM FDA UDI
- GMDN Term
- Non-specific circulating immune complex (CIC) IVD, kit, enzyme immunoassay (EIA) FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 864.4010 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Non-specific circulating immune complex (CIC) IVD, kit, enzyme immunoassay (EIA)
Genemed® by Sakura Finetek USA, Inc — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Non-specific circulating immune complex (CIC) IVD, kit, enzyme immunoassay (EIA).
- CIC-C1q ELISA Kit — Bühlmann Laboratories AG · Class II
- MicroVue — Quidel Corp. · Class II
- Genemed® — Sakura Finetek USA, Inc · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Sakura Finetek USA, Inc
Sources (1)
- FDA UDI fbd5a6f0-f58c-4983-a417-532c926e0805 35 fields · synced May 30, 2026